Esr1 Y537 mutations are associated with increased baseline circulating tumor cells enumeration for patients with estrogen receptor positive metastatic breast cancer

被引：0
|
作者：
Zhang, Qiang
Jiao, Jianhua
D'Amico, Paolo
Davis, Andrew A.
Qin, Weijun
Gerratana, Lorenzo
Jacob, Saya L.
Zhang, Youbin
Donahue, Jeannine
Qiang, Wenan
Shah, Ami N.
Flaum, Lisa
Gradishar, William
Platanias, Leonidas C.
Cristofanilli, Massimo
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P2-01-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-01-08
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Assessment of ESR1 and ERBB2 mutations in estrogen receptor positive (ER plus ) metastatic breast cancers (MBC).
    Basu, Gargi D.
    White, Tracey
    LoBello, Janine R.
    Kurdoglu, Ahmet
    Trent, Jeffrey M.
    Halbert, Matthew J.
    Royce, Thomas
    O'Shaughnessy, Joyce
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer
    Sefrioui, David
    Perdrix, Anne
    Sarafan-Vasseur, Nasrin
    Dolfus, Claire
    Dujon, Antoine
    Picquenot, Jean-Michel
    Delacour, Julien
    Cornic, Marie
    Bohers, Elodie
    Leheurteur, Marianne
    Rigal, Olivier
    Tennevet, Isabelle
    Thery, Jean-Christophe
    Alexandru, Cristina
    Guillemet, Cecile
    Moldovan, Cristian
    Veyret, Corinne
    Frebourg, Thierry
    Di Fiore, Frederic
    Clatot, Florian
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (10) : 2513 - 2519
  • [33] Comparison of ESR1 Mutations in Tumor Tissue and Matched Plasma Samples from Metastatic Breast Cancer Patients
    Takeshita, Takashi
    Yamamoto, Yutaka
    Yamamoto-Ibusuki, Mutsuko
    Tomiguchi, Mai
    Sueta, Aiko
    Murakami, Keiichi
    Omoto, Yoko
    Iwase, Hirotaka
    TRANSLATIONAL ONCOLOGY, 2017, 10 (05): : 766 - 771
  • [34] Estrogen receptor 1 (ESR1) mutations in circulating tumor DNA (ctDNA) from patients with ER+/HER2-metastatic breast cancer (mBC) treated with lasofoxifene or fulvestrant in the ELAINE 1 study
    Goetz, Matthew P.
    Gal-Yam, Einav
    Stover, Daniel
    Sammons, Sarah L.
    Graff, Stephanie L.
    Wang, Grace
    Cristofanilli, Massimo
    Riordan, Gary
    Sloane, Hillary S.
    Carroll, Dominic
    Plourde, Paul V.
    Portman, David J.
    CANCER RESEARCH, 2023, 83 (05)
  • [35] Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor
    Clatot, Florian
    Perdrix, Anne
    Augusto, Laetitia
    Beaussire, Ludivine
    Delacour, Julien
    Calbrix, Celine
    Sefrioui, David
    Viailly, Pierre-Julien
    Bubenheim, Michael
    Moldovan, Cristian
    Alexandru, Cristina
    Tennevet, Isabelle
    Rigal, Olivier
    Guillemet, Cecile
    Leheurteur, Marianne
    Gouerant, Sophie
    Petrau, Camille
    Thery, Jean-Christophe
    Picquenot, Jean-Michel
    Veyret, Corinne
    Frebourg, Thierry
    Jardin, Fabrice
    Sarafan-Vasseur, Nasrin
    Di Fiore, Frederic
    ONCOTARGET, 2016, 7 (46) : 74448 - 74459
  • [36] Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients
    Babayan, Anna
    Hannemann, Juliane
    Spoetter, Julia
    Mueller, Volkmar
    Pantel, Klaus
    Joosse, Simon A.
    PLOS ONE, 2013, 8 (09):
  • [37] Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer
    Lei, Jonathan T.
    Shao, Jieya
    Zhang, Jin
    Iglesia, Michael
    Chan, Doug W.
    Cao, Jin
    Anurag, Meenakshi
    Singh, Purba
    He, Xiaping
    Kosaka, Yoshimasa
    Matsunuma, Ryoichi
    Crowder, Robert
    Hoog, Jeremy
    Phommaly, Chanpheng
    Goncalves, Rodrigo
    Ramalho, Susana
    Rodrigues Peres, Raquel Mary
    Punturi, Nindo
    Schmidt, Cheryl
    Bartram, Alex
    Jou, Eric
    Devarakonda, Vaishnavi
    Holloway, Kimberly R.
    Lai, W. Victoria
    Hampton, Oliver
    Rogers, Anna
    Tobias, Ethan
    Parikh, Poojan A.
    Davies, Sherri R.
    Li, Shunqiang
    Ma, Cynthia X.
    Suman, Vera J.
    Hunt, Kelly K.
    Watson, Mark A.
    Hoadley, Katherine A.
    Thompson, E. Aubrey
    Chen, Xi
    Kavuri, Shyam M.
    Creighton, Chad J.
    Maher, Christopher A.
    Perou, Charles M.
    Haricharan, Svasti
    Ellis, Matthew J.
    CELL REPORTS, 2018, 24 (06): : 1434 - +
  • [38] Increased frequency of ESR1 mutation in metastatic breast cancer by dosing selective estrogen receptor modulator followed by aromatase inhibitor
    Takeshima, Kaoru
    Hayashida, Tetsu
    Maeda, Hinako
    Nakashoji, Ayako
    Yokoe, Takamichi
    Seki, Tomoko
    Takahashi, Maiko
    Kitagawa, Yuko
    ONCOLOGY LETTERS, 2020, 20 (02) : 1231 - 1238
  • [39] Study of ESR1 Expression and Estrogen Receptor Signaling Pathway in Breast Cancer Patients
    Leng, Bing
    Watson, Linden
    Dowell, Angeline
    Walker, Kimberly
    Rao, Arundhati
    LABORATORY INVESTIGATION, 2015, 95 : 53A - 53A
  • [40] Epigenetic silencing promotor gene of ESR1 in DNA circulating and not expression of estrogen receptor in tumors of patients with breast cancer
    Martinez-Galan, J.
    Delgado, J. R.
    Del Moral, R.
    Torres-Torres, B.
    Ros, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S37 - S37
12345